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Abstract
Progress is reviewed towards the development of a global strategy that aims to extend the
sensitivity, dynamic range, comprehensiveness and throughput of proteomic measurements
based upon the use of high performance separations and mass spectrometry. The approach
uses high accuracy mass measurements from Fourier transform ion cyclotron resonance
mass spectrometry (FTICR) to validate peptide ‘accurate mass tags’ (AMTs) produced by
global protein enzymatic digestions for a speciﬁc organism, tissue or cell type from
‘potential mass tags’ tentatively identiﬁed using conventional tandem mass spectrometry
(MS/MS). This provides the basis for subsequent measurements without the need for MS/
MS. High resolution capillary liquid chromatography separations combined with high
sensitivity, and high resolution accurate FTICR measurements are shown to be capable of
characterizing peptide mixtures of more than 10
5 components. The strategy has been
initially demonstrated using the microorganisms Saccharomyces cerevisiae and Deinococ-
cus radiodurans. Advantages of the approach include the high conﬁdence of protein
identiﬁcation, its broad proteome coverage, high sensitivity, and the capability for stable-
isotope labeling methods for precise relative protein abundance measurements.
Abbreviations: LC, liquid chromatography; FTICR, Fourier transform ion cyclotron
resonance; AMT, accurate mass tag; PMT, potential mass tag; MMA, mass measurement
accuracy; MS, mass spectrometry; MS/MS, tandem mass spectrometry; ppm, parts per
million. Copyright # 2002 John Wiley & Sons, Ltd.
Keywords: Fourier transform ion cyclotron resonance; mass spectrometry; proteome;
proteins; D. radiodurans
Introduction
The ability to study how the components of a
biological cell or organism change and interact
following a perturbation provides a foundation to
understand the function(s) of its component parts,
and ultimately how the system operates. Reaching
this goal will require instrumental and computa-
tional methods that identify systems-level responses
that recognize genes or gene products that are
sensitive to changes in the environment of the cell
or organism. Thus, considerable attention is now
focused on the proteome, the complement of pro-
teins expressed by a particular cell, organism or
tissue at a given time or under a speciﬁc set of
environmental conditions.
The currently existing proteome analysis capabil-
ity is predominantly based upon protein separations
using two-dimensional polyacrylamide gel electro-
phoresis (2D PAGE). While 2D PAGE is capable of
resolving thousands of proteins, proteome cover-
age is problematic for proteins that have very high
or low isoelectric points (<y3.5 and >y9.5),
extremes of molecular weight, and membrane
proteins, which typically account for more than
half of all the proteins expressed within a cell. It has
been shown that the number of spots is often poorly
correlated with the number of different proteins
detected, since a single gene can give rise to multiple
spots [4] due to co- and post-translational modiﬁca-
tions, degradation intermediates and alternative
expression (e.g. alternative splicing of mRNAs,
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PAGE is generally limited to femtomole levels
[11,14] by the need to visualize the protein spot on
the gel and its subsequent processing and analysis
primarily using mass spectrometry (MS) [10,14,15].
Finally, the precision of protein abundance deter-
minations using 2D PAGE is based on comparison
of protein spot intensities, limiting the capability for
discerning subtle differences in protein abundances
for large numbers of proteome-wide measurements
[12].
Here we review the technological basis and pro-
gress towards a global proteomics strategy that
aims to provide large improvements in sensitivity,
dynamic range, comprehensiveness and throughput
based upon the use of peptide ‘accurate mass tags’
(AMTs) [3]. The two-stage strategy exploits high
resolution capillary LC separation combined with
Fourier transform ion cyclotron resonance mass
spectrometry mass spectrometry (FTICR) to vali-
date peptide AMTs for a speciﬁc organism, tissue
or cell type [2,6,9]. AMTs are peptide biomarkers
that are used to conﬁdently identify a unique pro-
tein based on the high mass measurement accuracy
provided by FTICR. The identiﬁcation of these
biomarkers using tandem mass spectrometry (i.e.
MS/MS) provides the basis for second-stage high
throughput studies using only AMTs to identify
and quantify the proteins expressed within a cell
system. Key attractions of the approach include the
feasibility of completely automated high conﬁdence
protein identiﬁcations, extensive proteome cover-
age, and the capability for exploiting stable-isotope
labeling methods for high precision abundance
measurements [13]. Additional developments, includ-
ing the use of multiplexed-MS/MS capabilities [6],
methods for dynamic range expansion of proteome
measurements, [1] and multi-stage separations also
promise to enable more focused analyses and
further extend the quality of measurements and
their extension to more complex proteomes.
The new proteome measurement
technology and applications
The aim of our strategy for proteome analysis
developed over the last several years is to exploit a
combination of instrumental and methodological
approaches to provide broad proteome coverage,
high sensitivity and the capability for greatly
increased throughput compared with conventional
technologies [13]. After initial cell lysis the recov-
ered proteins are enzymatically digested into pep-
tide fragments (e.g. using trypsin) to produce tens
to hundreds of potentially detectable peptides (and
modiﬁed peptides) from each protein, and perhaps
10
5 to >10
6 in total (depending upon proteome
complexity, the dynamic range of the measurements
etc.). This complex peptide mixture is then analyzed
by combined high resolution capillary separations-
FTICR.
The extent of proteome coverage for any
approach depends substantially on the achievable
dynamic range of the MS measurements, which in
turn depends signiﬁcantly upon the resolution (or
peak capacity) of the separation step(s) preceding
MS analyses and any overall constraints due to
sensitivity. As shown by the example in Figure 1,
the dynamic range obtainable in a single FTICR
mass spectrum exceeds 10
3. The most highly
abundant peptide eluted over a series of spectra,
while low abundance peptides are often detected
within a single spectrum. Therefore, the effective
dynamic range for detection of peptides is y10
4.
Furthermore, if one’s aim is protein identiﬁcation,
then a signiﬁcant (perhaps 10-fold) increase in
effective dynamic range will result due to the vari-
able ESI or detection efﬁciency for different peptide
sequences, and we estimate that the dynamic range
achieved here initially is approximately 10
4 to 10
5
[9].
The power of MS for protein identiﬁcation
derives from the speciﬁcity of mass measurements
for either the intact peptides or their fragments after
dissociation in MS/MS measurements, and is
implicitly based upon the relatively small number
of possible peptide sequences for a speciﬁc organism
compared to the total number of possible sequen-
ces (see Table 1). The distinctiveness of peptide
sequences increases with size, but in practice the
utility of increased size for identiﬁcation is miti-
gated by the increased likelihood that a peptide will
be unpredictably modiﬁed. Though much smaller
than the number of possible sequences, the number
of potentially distinguishable peptide masses, given
sufﬁcient resolution and accuracy, also dwarfs the
number of predicted peptides from any organism.
As shown in Table 2, an ideal tryptic digestion of all
yeast proteins would produce 194 239 peptides
having masses between 500 and 4000 Da, the range
typically studied by MS. Of these, 34% are unique
at t0.5 ppm MMA. (A larger fraction is unique if
constrained by additional information resulting
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of LC elution times.) These distinctive peptide
masses would cover 98% and 96.6% of all predicted
S. cerevisiae and C. elegans proteins, respectively.
Thus, given sufﬁcient MMA, a peptide mass
measurement can often be conﬁdently attributed to
a single protein within the constraints provided by a
single genome sequence and its predicted proteome
(i.e. serve as an accurate mass tag; an AMT). The
AMT strategy obviates the routine need for MS/MS
for peptide identiﬁcation, and thus reduces sample
requirements. Since the masses of many peptides
Figure 1. Illustration of the high quality of FTICR data (top) and the LC summed ion signal intensity during the separation
(bottom) for a capillary LC-FTICR analysis of a soluble yeast protein digest. The separation was conducted at 10 000 psi to
afford a LC peak capacity of y800, as illustrated by the narrow peak widths (bottom). The high magnetic ﬁeld FTICR
instrumentation simultaneously provides high dynamic range, resolution, sensitivity and mass measurement accuracy. As a
result, more than 100 000 species can be distinguished in a single analysis
Table 1. Number of possible peptides and number predicted for three organisms from digestion with trypsin
Length
Possible Predicted number of peptides
3
Sequences
1 Masses
2 D. radiodurans S. cerevisiae C. elegans
10-mers 10
13 2r10
7 3471 11 275 30 623
20-mers 10
26 7r10
10 1292 3463 9475
30-mers 10
39 2r10
13 494 1278 3602
40-mers 10
52 1r10
15 195 405 1295
1Assumes 20 possible distinguishable amino acid residues.
2The number of peptides of length r potentially distinguishable by mass based upon the number of possible combinations of n different amino
acids. (n+r-1)!/r! (n-1)!. The actual number of possible masses is somewhat smaller due to some mass degeneracy. The number of distinguishable
peptides in actual measurements depends upon the MS resolution.
3Predicted from the identiﬁed open reading frames and applying the cleavage speciﬁcity of trypsin.
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requiring equivalent or less time than one MS/MS
measurement, the increase in throughput is at the
least equal to the average number of peptides in
each spectrum. In practice the increase in either
throughput or proteome coverage is even greater
since the lower abundance peptides are often not
analyzed by conventional MS/MS approaches, or
require the need for additional time for extended
ion accumulation or spectrum averaging to yield
spectra of sufﬁcient quality. Thus, the AMT
approach provides increased sensitivity, coverage
and throughput, and facilitates quantitative studies
involving many analyses of different perturbations
or time points.
The generation of most AMTs by this approach
presently uses a two-stage process (Figure 2). The
proteome sample is digested (e.g. with trypsin) and
analyzed by high efﬁciency capillary LC-MS/MS
using either a conventional (LCQ ion trap or
Q-TOF) mass spectrometer operating in a data-
dependent mode or using FTICR. The ion trap MS/
MS measurements yield ‘potential mass tags’
(PMTs) that are subsequently validated as AMTs
if the predicted peptide’s accurate mass is observed
using FTICR in a corresponding sample and at an
equivalent elution time [13].
Ion trap MS/MS generated PMTs were initially
identiﬁed using ‘scores’ produced by the SEQUEST
search program based upon the similarity of the
spectrum with a set of peaks predicted on the basis
of the known most common peptide fragmentation
processes. Due to the nature of the analysis, the
results will invariably span the range from low
scores where identiﬁcations are highly doubtful, to
high scores where identiﬁcations are quite reliable,
with no clear line of demarcation. If one uses only
the highest scores for identiﬁcation, fewer proteins
will be identiﬁed, however, uncritical use of lower
scores will result in many false identiﬁcations.
Conventionally, many MS/MS spectra need to be
manually examined so as to establish acceptable
conﬁdence for identiﬁcations. This process generally
results in discarding a substantial fraction of the
peptides identiﬁed with lower scores, and serves to
increase the conﬁdence to an extent that is difﬁcult
to quantify. In our approach the use of highly
accurate mass measurements provides an addi-
tional, high quality ‘test’ for tentative peptide
identiﬁcations that can be applied in the data
analysis using software developed at our laboratory.
A consequence of the automated validation of
AMTs from PMTs is the increased conﬁdence in
the peptide identiﬁcations that results. Once a
protein has been identiﬁed using AMTs, its sub-
sequent identiﬁcation (and quantitation) in other
studies is based on FTICR measurements (and its
elution time), which provide much greater sensitiv-
ity than the conventional MS instrumentation.
Once an AMT has been established, it can be
used to conﬁdently identify a speciﬁc protein in
subsequent proteome studies. Without the need to
re-establish the identity of a peptide using MS/MS
analyses, multiple high throughput studies focused
on measuring changes in relative protein abun-
dances between two (or more) different proteomes
are facilitated. In such comparative studies, stable
isotope labeling methods can be used to provide a
means to measure protein relative abundances, a
process that also beneﬁts from the resolution and
sensitivity of the FTICR measurements.
Several strategies have been applied in our initial
work with D. radiodurans to increase the number of
AMTs so as to subsequently routinely allow lower-
level proteins to be analyzed by this approach [13].
First, samples were analyzed several times using the
same capillary LC-MS/MS strategy, but with differ-
ent m/z ranges and with the ‘exclusion’ of parent
ions that were previously selected for MS/MS,
resulting in the selection of different peptides and
Table 2. Predicted number of peptides
1 for ideal global tryptic digestions
Organism Peptides
1 Unique
2 ORF Coverage
3 Cys-peptides
1 Unique
2 ORF Coverage
3
D. radiodurans 60 068 51.4% 99.4% 4906 87.2% 66%
E. coli 84 162 48.6% 99.1% 11 487 83.6% 80%
S. cerevisiae 194 39 33.9% 98% 27 483 72.7% 84%
C. elegans 527 863 20.9% 96.6% 108 848 52.5% 92%
1Peptides or Cys-peptides in mass range of 500 to 4000 Da, assuming ideal trypsin cleavage speciﬁcity.
2Percent unique to t0.5 ppm (by mass not using elution time).
3Percent of ORFs (or predicted proteins) covered by unique peptides.
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in instrumental approaches, proteome samples
extracted from cells harvested at different growth
phases (i.e. mid-log, stationary phase, etc.) or cul-
tured under a variety of different conditions (i.e.
nutrients, perturbations) were also analyzed. By
varying growth conditions and harvesting stages,
the potential pool of PMTs increases signiﬁcantly
since the absolute number of proteins collectively
present in the different samples is signiﬁcantly
greater than the number expressed by the organism
under a single growth condition. Finally, since any
additional sample fractionation will increase the
overall dynamic range achievable, peptide fractions
were also analyzed after ﬁrst being separated off-
line by ion exchange chromatography, and which
again results in the generation of large numbers of
additional PMTs for peptides that would otherwise
have too low abundance for conventional MS/MS
analyses. The PMT generation efforts continued
for D. radiodurans for over 200 different ion trap
MS/MS runs, and until the rate of generation of
novel PMTs decreased signiﬁcantly. Since the
analysis procedure can be totally automated, this
Figure 2. Experimental steps involved in establishing an accurate mass tag (AMT) illustrated by the identiﬁcation of an AMT
for elongation factor Tu (EF-Tu). Peptides are automatically selected for collisional induced dissociation (CID) and tentatively
identiﬁed as a potential mass tag (PMT) using an automated search program (SEQUEST). In this example a tryptic peptide
from EF-Tu (in bold) was identiﬁed by tandem MS (MS/MS) using an ion trap mass spectrometer. The accurate mass of this
PMT was calculated based on its sequence and its elution time recorded. In the second stage, the same proteome sample is
analyzed under the same LC-MS conditions using a high-ﬁeld FTICR mass spectrometer. An AMT is established when a
peptide eluting at the same time and corresponding to the calculated mass (e.g. within 1 ppm) of the PMT identiﬁed in the
ﬁrst stage is observed. This peptide is then considered an AMT for EF-Tu for D. radiodurans and functions as a biomarker to
identify this particular protein in all subsequent experiments
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mately three weeks using a single ion trap instru-
ment, and additional experience should signiﬁcantly
reduce the number of runs required for PMT
generation. It should be noted that any number of
alternative sample fractionation and analysis stra-
tegies can be preformed to increase the number of
PMTs and AMTs generated, and that the extra
efforts at this stage are rewarded by the ability to
subsequently make more comprehensive proteome
measurements.
Analyses using D. radiodurans cultured under a
number of different growth conditions, typically
resulted in the detection of 20 000 to >50 000
peptides by capillary LC-FTICR analysis in each
analysis (Figure 3). Using capillary LC with MS/
MS measurements (including ion trap MS/MS
measurements that generated >9000 PMTs), a
total of 6997 peptides were validated as bona ﬁde
AMTs. These AMTs provide conﬁdent identiﬁca-
tion of 1910 predicted proteins (with an average of
>3 AMTs per protein), covering y61% of the
predicted proteome and spanning every category of
predicted protein function from the annotated
genome.
Proteome measurements often involve comparing
protein abundances between two cellular popula-
tions resulting from, for example, some insult or
perturbation. The predominant method for measur-
ing changes in protein expression levels using
Figure 3. Two-dimensional display of peptides based on their molecular weight (MW) and elution order (i.e. FTICR
spectrum number) and identiﬁed AMTs from Deinococcus radiodurans. The circled spots in the inset show spots that were
identiﬁed as AMTs in the enlarged region. The spots are labeled based on their annotation within the organism’s genome
sequence (i.e. DR0309; elongation factor Tu) and the tryptic peptide of the protein that was identiﬁed (i.e. t25; the 25
th
tryptic peptide counting from the amino terminus, based on complete digestion)
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intensities of the corresponding 2D PAGE spots.
Attempts to infer absolute peptide abundances
based upon MS signal intensities can be proble-
matic for reasons that include variations in ion-
ization efﬁciencies and losses during sample
preparation and separations, and while useful for
large differences in abundances, are unsuited to
study more subtle variations. The generation and
use of AMTs enables high throughput and high
precision expression studies based upon stable-
isotope labeling by directly comparing two pro-
teomes in the same analysis (e.g. utilizing a
‘reference proteome’ to which perturbed systems
are compared). A stable-isotope labeled reference
proteome, for example, provides an effective inter-
nal standard for each protein, and hence their
tryptic peptides, allowing changes in protein abun-
dances based upon the relative abundances of
AMTs to be assessed, potentially to precisions
better than 10% [5,7,8]. While such measurements
require both versions of the protein or peptide to be
present, it should be feasible to combine this
information with absolute peak intensity data to
provide less precise abundances for cases where
only one peptide is detected, and to also establish
approximate absolute abundances (albeit, with less
precision).
The large variation of protein relative abun-
dances having potential biological signiﬁcance in
mammalian systems (>6 orders of magnitude) pre-
sents a major challenge for proteomics. We have
recently developed a new Dynamic Range Enhance-
ment Applied to Mass Spectrometry (DREAMS)
approach that provides the basis for a signiﬁcant
gain in the coverage of proteomic measurements [1].
The DREAMS methodology involves acquisition of
sets of mass spectra during the non-selective
accumulation, in which each spectrum is followed
by software-controlled selection of the most abun-
dant ion peaks based on their quadrupole secular
frequencies and then selective rf-only ejection of the
most abundant species prior to external accumula-
tion (for the next spectrum immediately following
the non-selective ‘normal’ spectrum). This initial
demonstration of the DREAMS FTICR method
generated two data sets comprising spectra for the
detected peptide isotopic distributions from the
non-selective and selective DREAMS accumula-
tions. It was found that the number of peptides
detected with the alternating sequences (30 771 after
subtraction of species detected in both) was greater
by about 35% than that acquired using the non-
selective ion accumulation (22 664). The same
methodology was subsequently applied with data-
dependent selective ion ejection of the two and three
most abundant ion species. A 40% increase in the
number of peptides was achieved when combining
the non-selective ion accumulation with data-
dependent selective ion ejection of the three most
abundant ion species [1]. We believe that the
DREAMS FTICR technology is an important
component of an approach that provides the basis
for a signiﬁcant gain in the coverage of proteomic
measurements.
While much remains to be done to reﬁne and
fully establish the high throughput potential of this
approach, it clearly offers signiﬁcant advantages in
throughput, dynamic range and the completeness of
proteome coverage. The approach described gen-
erates enormous quantities of data, which the initial
work has only partly exploited. However, one can
anticipate that this situation will change rapidly as
additional and more powerful data analysis tools
are implemented.
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